Skip to content

    RELMADA THERAPEUTICS (RLMD) stock price & financials

    View RLMD earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance+546.3% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    Operating Profit
    -$23.01M
    -$19.08M
    -$18.22M
    -$10.22M
    -$10.33M
    +55.1%
    -$20.33M
    -6.6%
    -$19.46M
    -6.8%
    -$15.01M
    -46.9%
    Weakening
    Net Profit
    -$21.73M
    -$18.66M
    -$17.56M
    -$9.87M
    -$10.09M
    +53.6%
    -$19.87M
    -6.5%
    -$19.05M
    -8.5%
    -$12.91M
    -30.9%
    Weakening
    EPS
    $-0.72
    $-0.58
    $-0.30
    $-0.30
    +58.3%
    $-0.22
    +62.1%
    $-0.11
    +63.3%
    Strengthening
    Other Income
    $1.28M
    $418.4K
    $659.0K
    $354.9K
    $235.8K
    -81.6%
    $465.4K
    +11.2%
    $409.8K
    -37.8%
    $2.10M
    +490.9%
    Strengthening
    Interest
    Depreciation
    Profit before Tax
    MarginsOPM
    Tax
    ReturnsROIC
    3.0%
    2.6%
    2.4%
    1.4%
    1.4%
    -53.6%
    2.7%
    +6.5%
    2.6%
    +8.5%
    1.8%
    +30.9%
    Strengthening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY19FY19FY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$9.22M$36.28M$2.50M$44.44M$5.40M$4.09M$3.86M$3.50M$11.33M
    Short-Term Investments
    Total Current Assets$9.98M$116.94M$118.07M$223.30M$152.87M$97.51M$45.80M$93.98M$219.04M
    Net PP&E$7.2K$5.0K$1.3K
    Goodwill
    Intangibles
    Total Assets$10.22M$117.14M$118.19M$223.33M$152.91M$97.55M$45.82M$94.00M$219.06M
    LiabilitiesTotal Current Liabilities$2.61M$1.46M$12.60M$15.06M$12.47M$12.19M$10.29M$6.43M$7.42M
    Short-Term Debt
    Long-Term Debt
    Long-Term Leases
    Total Liabilities$2.61M$1.46M$12.60M$15.06M$12.47M$12.19M$10.30M$7.49M$12.50M
    EquityCommon Stock & APIC$9.7K$14.5K$16.3K$27.7K$30.1K$30.1K$30.2K$73.3K$106.7K
    Retained Earnings-$111.66M-$119.86M-$179.32M-$305.07M-$462.11M-$560.90M-$640.88M-$698.27M-$730.23M
    Total Equity$7.61M$115.68M$105.58M$208.26M$140.44M$85.36M$35.52M$86.51M$206.56M
    HighlightsNet Cash / (Debt)

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY19FY19FY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating-$10.50M-$12.09M-$27.81M-$91.87M-$103.80M-$51.66M-$51.76M-$45.79M-$45.99M
    Cash from Investing-$80.16M-$34.45M-$54.12M$19.73M$50.45M$51.56M-$48.14M-$187.82M
    Cash from Financing$17.48M$126.11M$28.47M$187.94M$45.02M-$98.5K-$40.3K$93.56M$243.79M
    SummaryCapital Expenditure-$84.85M-$182.05M
    Free Cash Flow-$96.94M-$209.86M
    FCF Margin

    Ratios